-- Q4 SaaS revenue grows 19% as record incremental bookings fuels ARR3
growth of 20% and an RPO balance approaching $1 billion
-- Delivered record Q4 profit and adjusted EBITDA2, adjusted EBITDA
margin2 up to 26% as operating leverage improves
-- Fiscal 2025 SaaS revenue growth hits 17% and Adjusted EBITDA margin2
rises to 25%, demonstrating ongoing balance between strong growth and
profitability
OTTAWA, Ontario--(BUSINESS WIRE)--March 04, 2026--
Kinaxis$(R)$ (TSX:KXS), a global leader in end-to-end supply chain orchestration, reported record results for its fourth quarter ended December 31, 2025. All amounts are in U.S. dollars. All figures are prepared in accordance with IFRS Accounting Standards (IFRS) unless otherwise indicated.
"Our team delivered a record fourth quarter and fiscal 2025. The results demonstrate the growing need for organizations to manage unprecedented levels of volatility in demand and supply with Maestro, our market-leading AI-enabled supply chain planning, decision-making and orchestration platform," said Razat Gaurav, chief executive officer at Kinaxis. "Our improved focus on large, global organizations that run complex supply chains is paying off, including new wins with leaders in semiconductors, data storage, oil and gas, among others. We also had a record year expanding with our installed base, reflecting enhanced focus and execution in that key go-to-market motion and a much broader set of capabilities in Maestro. Our customers are strategically partnering with Kinaxis to reimagine their supply chain planning, leverage state-of-the-art data and semantic architectures, and rapidly innovate with our composable agentic orchestration capabilities."
Q4 2025 Highlights
$ USD thousands, except as otherwise
indicated Q4 2025 Q4 2024 Change
---------------------------------------------- ---------- ---------- ------
Total Revenue 144,235 16%
(constant currency(2) ) 140,786 123,935 14%
---------------------------------------------- ---------- ---------- ------
SaaS 97,153 19%
(constant currency(2) ) 94,974 81,856 16%
Subscription term licenses 1,716 1,592 8 %
Professional services 39,951 35,092 14 %
Maintenance and support 5,415 5,395 --%
---------------------------------------------- ---------- ---------- ------
Gross profit 94,259 75,102
Margin 65% 61% 26%
---------------------------------------------- ---------- ---------- ------
Profit (loss) 19,501 (16,316)
Per diluted share $0.68 $(0.58) --(1)
---------------------------------------------- ---------- ---------- ------
37,575 31,462
Adjusted EBITDA(2) Margin 26% 25% 19%
---------------------------------------------- ---------- ---------- ------
Cash flows from operating activities 29,942 24,117 24%
---------------------------------------------- ---------- ---------- ------
(1) The Percentage change has been excluded as it is not meaningful.
(2) "Adjusted EBITDA" and constant currency metrics are non-IFRS measures that
are not a recognized, defined or standardized measure under IFRS. These
measures as well as any other non-IFRS financial measures reported by Kinaxis
are defined in the "Non-IFRS Measures" section of this news release.
FY 2025 Highlights
$ USD thousands, except as otherwise indicated FY 2025 FY 2024 Change
------------------------------------------------ --------- --------- ------
Total Revenue 548,030 13%
(constant currency(2) ) 540,204 483,111 12%
------------------------------------------------ --------- --------- ------
SaaS 362,427 17%
(constant currency(2) ) 357,501 309,243 16%
------------------------------------------------ --------- --------- ------
138,370 106,085
Adjusted EBITDA(2) Margin 25% 22% 30%
------------------------------------------------ --------- --------- ------
Key Performance Indicators
The company's Annual Recurring Revenue(3) $(ARR)$, which includes subscription amounts related to both SaaS and on-premise contracts, rose 20% to $433 million at the end of the quarter (18% growth in constant currency(2) .
$USD millions Q4 2025 Q4 2024 Change --------------------------------------- ------------ ----------- ---------- Annual recurring revenue(3) 433 360 20 % --------------------------------------- ------------ ----------- ---------- (3) Annual Recurring Revenue (ARR) is the total annualized value of recurring subscription amounts (ultimately recognized as SaaS, Subscription term licenses and Maintenance and support revenue) of all subscription contracts at a point in time. Annualized subscription amounts are determined solely by reference to the underlying contracts, normalizing for the varying revenue recognition treatments under IFRS 15 for cloud-based versus on-premise subscription amounts. It excludes one-time fees, such as for non-recurring professional services, and assumes that customers will renew the contractual commitments on a periodic basis as those commitments come up for renewal, unless such renewal is known to be unlikely. We believe that this measure provides a more current indication of our performance in the growth of our subscription business than other metrics.
The nature of the company's long-term contracts provides visibility into future, contracted revenue. The following table presents revenue expected to be recognized in the future related to performance obligations that are unsatisfied (or partially unsatisfied) at December 31, 2025.
$USD millions 2026 2027 2028 and later Total
---------------------------- ----- ----- -------------- -----
SaaS 374.5 273.0 254.6 902.1
---------------------------- ----- ----- -------------- -----
Maintenance and support 20.3 16.4 10.6 47.3
---------------------------- ----- ----- -------------- -----
Subscription term licenses 18.1 3.4 0.3 21.8
---------------------------- ----- ----- -------------- -----
Total 412.9 292.8 265.5 971.2
---------------------------- ----- ----- -------------- -----
Financial Guidance
Kinaxis is initiating its fiscal 2026 financial guidance, as follows.
FY 2026 Guidance
--------------------------- ----------------
Total revenue $620-635 million
--------------------------- ----------------
SaaS revenue growth 17-19% growth
--------------------------- ----------------
Adjusted EBITDA(2) margin 25-26%
--------------------------- ----------------
"2025 was an outstanding year for Kinaxis, both from a growth and profitability perspective. We roughly doubled the number of wins with large enterprise customers and saw over 100 software deals above $1 million in total software contract value and more than 20 deals above $1 million in average annual software contract value. We exited the year with ARR growing 18% in constant currency versus 14% last year, which creates an opportunity for momentum in SaaS revenue and Adjusted EBITDA margin in 2026, even as we make important investments in AI and in our high-performing go-to-market organization," said Blaine Fitzgerald, chief financial officer at Kinaxis.
Guidance in this press release is provided to enhance visibility into Kinaxis' expectations for financial targets for the periods indicated. Please refer to the section regarding forward-looking statements that forms an integral part of this release. This press release along with the financial statements and MD&A for the quarter ended December 31, 2025 are available on Kinaxis' website and on SEDAR+ at www.sedarplus.ca.
Conference Call
Kinaxis will host a conference call tomorrow, March 5, 2026, to discuss these results. Razat Gaurav, chief executive officer, and Blaine Fitzgerald, chief financial officer, will host the call starting at 8:30 a.m. Eastern Time. A question and answer session will follow management's presentation.
DATE: Thursday, March 5, 2026
TIME: 8:30 a.m. Eastern Time
WEBCAST https://events.q4inc.com/attendee/567578009 (available for three
months)
About Kinaxis Inc.
Kinaxis is a global leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro$(TM)$, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain -- from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today's volatility and disruption. For more news and information, please visit kinaxis.com or follow us on LinkedIn.
Non-IFRS Measures
This press release makes reference to Adjusted Profit and Adjusted EBITDA, which are non-IFRS financial measures, as well as Adjusted EBITDA margin which expresses Adjusted EBITDA as a percentage of revenue. Adjusted Profit, Adjusted EBITDA and Adjusted EBITDA margin are not recognized, defined or standardized measures under IFRS. We use these measures to provide investors with supplemental information on our operating performance and to highlight trends in our core business that may not otherwise be apparent when relying solely on IFRS financial measures. We believe that securities analysts, investors and other interested parties frequently use non-IFRS measures in the evaluation of issuers. Providing these non-IFRS measures provides useful information because they portray the financial results of the Company before certain expenses that do not impact the ongoing operating decisions taken by management. Management also uses non-IFRS measures in order to facilitate operating performance comparisons from period to period, prepare annual operating budgets and assess our ability to meet our capital expenditure and working capital requirements, and to determine components of employee compensation.
Adjusted Profit represents profit adjusted to exclude our equity compensation plans, special charges, and restructuring expenses. Adjusted EBITDA represents profit adjusted to exclude our equity compensation plans, special charges, restructuring expenses, income tax expense, depreciation and amortization, foreign exchange loss (gain) and net finance (income) expense. Adjusted EBITDA margin expresses Adjusted EBITDA as a percentage of revenue. Our definitions of Adjusted Profit, Adjusted EBITDA and Adjusted EBITDA margin will likely differ from those used by other companies (including our peers) and therefore comparability may be limited. Non-IFRS measures should not be considered a substitute for or in isolation from measures prepared in accordance with IFRS. Investors are encouraged to review our financial statements and disclosures in their entirety and are cautioned not to put undue reliance on non-IFRS measures and view them in conjunction with the most comparable IFRS financial measures. Kinaxis has reconciled Adjusted Profit and Adjusted EBITDA to the most comparable IFRS financial measure as follows:
Three months ended
December 31, Year ended December 31,
------------------------- -------------------------
2025 2024 2025 2024
------------ ----------- ------------ -----------
(In thousands of USD) (In thousands of USD)
Profit (loss) 19,501 (16,316) 70,699 56
Share-based
compensation 9,263 10,228 39,015 39,581
Special
charges(1) -- 18,191 -- 21,365
Restructuring
expenses(2) -- (71) -- 7,249
------ ---- ------- ------- --- -------
Adjusted profit 28,764 12,032 109,714 68,251
====== ==== ======= ======= === =======
Income tax
expense 7,329 17,068 22,187 25,096
Depreciation
and
amortization 4,586 6,046 19,847 24,928
Foreign
exchange gain (356) (927) (2,561) (682)
Net finance
income (2,748) (2,757) (10,817) (11,508)
------ --- ------- ------- -------
8,811 19,430 28,656 37,834
------ ---- ------- ------- --- -------
Adjusted EBITDA 37,575 31,462 138,370 106,085
====== ==== ======= ======= === =======
Adjusted EBITDA
as a
percentage of
revenue 26% 25% 25% 22%
Note:
(1) Costs associated with business transformation activities.
(2) Costs associated with the restructuring initiative
We also present certain IFRS measures, SaaS revenue and total revenue, and non-IFRS supplementary measures, ARR, under constant currency. We believe that presenting these measures under constant currency provides a useful framework for assessing estimates of how our business would have performed excluding the effect of foreign currency rate fluctuations. The presentation of financial results under constant currency is considered to be a non-IFRS measure and does not have any standardized meaning under IFRS. As a result, the information presented may not be comparable to similar measures presented by other companies (including our peers). For SaaS revenue and total revenue under constant currency, results for entities reporting in currencies other than U.S. Dollars ("USD") are converted into USD at the average exchange rates in effect during the comparison period, rather than the actual average exchange rates in effect during the current period. For constant currency ARR, we convert all non-USD-denominated recurring subscription amounts at the exchange rates in effect at the end of the comparison period, rather than the exchange rates in effect at the end of the current period. The outlook for constant currency SaaS revenue growth rate is derived by applying the average exchange rates in effect during the comparison period rather than the exchange rates expected during the guidance period. We believe the presentation of the above results and metrics, and applicable related growth rates, adjusted for constant currency facilitates the corresponding year--over--year comparisons.
Forward-Looking Statements
Certain statements in this release constitute forward-looking statements, future-oriented financial information and financial outlook within the meaning of applicable securities laws. Forward-looking statements, future-oriented financial information and financial outlook include statements as to our expectations for:
-- growth of annual total revenue, annual SaaS revenue growth, and our
expectations for Adjusted EBITDA margin achievement, in each case looking
forward for our fiscal year ending December 31, 2026;
-- SaaS growth and increased profitability in years beyond 2026; and
-- contracted revenue in future periods, including 2026, 2027 and 2028 and
later.
This release also includes forward-looking statements as to Kinaxis' growth opportunities and the potential benefits of, and markets and demand for, Kinaxis' products and services. These statements are subject to certain assumptions, risks and uncertainties, including our view of the relative position of Kinaxis' products and services compared to competitive offerings in the industry.
In particular, our guidance for 2026 annual total revenue, annual SaaS revenue growth and annual Adjusted EBITDA margin, as well as our comments on our expectations for SaaS growth and increased profitability in years beyond 2026, are subject to certain assumptions and associated risks including:
-- our ability to win business from new customers and expand business from
existing customers;
-- the timing of new customer wins and expansion decisions by our existing
customers;
-- maintaining our customer retention levels, and specifically, that
customers will renew contractual commitments on a periodic basis as those
commitments come up for renewal, at rates consistent with our historic
experience;
-- anticipated trends, standards and challenges in our business and the
markets we operate in;
-- fluctuations in the value of foreign currencies relative to the U.S.
Dollar; and
-- with respect to Adjusted EBITDA and profitability, our ability to
contain expense levels while expanding our business.
Our guidance and commentary for achievement of contracted revenue in future periods, including in 2026, 2027 and 2028 and later, is based on assumptions and associated risks including:
-- our ability to satisfy material unperformed obligations under our
long-term contracts; and
-- the continued financial capacity and creditworthiness of our customers
under long-term contracts.
These and other assumptions, risks and uncertainties may cause Kinaxis' actual results, performance, achievements and developments to differ materially from the results, performance, achievements or developments expressed or implied by forward-looking statements, future-oriented financial information or financial outlook. Material risks and uncertainties relating to our business are described under the headings "Forward-Looking Statements" and "Risks and Uncertainties" in our annual MD&A dated March 4, 2026, and under the heading "Risk Factors" in our Annual Information Form dated March 4, 2026, which are available at www.sedarplus.ca. Readers are cautioned that the assumptions used in the preparation of forward-looking statements, future-oriented financial information and financial outlook, although considered reasonable at the time of preparation, may prove to be imprecise or inaccurate and, as such, undue reliance should not be placed on such information. Our actual results, performance and achievements could differ materially from those expressed in, or implied by, such forward-looking statements, future-oriented financial information or financial outlook. Forward-looking statements, future-oriented financial information and financial outlook are provided to help readers understand management's expectations as at the date of this release and may not be suitable for other purposes. Readers are cautioned not to place undue reliance on forward-looking statements. Kinaxis assumes no obligation to update or revise any
forward-looking statements, future-oriented financial information or financial outlook whether as a result of new information, future events or otherwise, except as expressly required by law.
These and other assumptions, risks and uncertainties may cause Kinaxis' actual results, performance, achievements and developments to differ materially from the results, performance, achievements or developments expressed or implied by forward-looking statements, future-oriented financial information or financial outlook. Material risks and uncertainties relating to our business are described under the headings "Forward-Looking Statements" and "Risks and Uncertainties" in our annual MD&A dated March 4, 2026, and under the heading "Risk Factors" in our Annual Information Form dated March 4, 2026, which are available at www.sedarplus.ca. Readers are cautioned that the assumptions used in the preparation of forward-looking statements, future-oriented financial information and financial outlook, although considered reasonable at the time of preparation, may prove to be imprecise or inaccurate and, as such, undue reliance should not be placed on such information. Our actual results, performance and achievements could differ materially from those expressed in, or implied by, such forward-looking statements, future-oriented financial information or financial outlook. Forward-looking statements, future-oriented financial information and financial outlook are provided to help readers understand management's expectations as at the date of this release and may not be suitable for other purposes. Readers are cautioned not to place undue reliance on forward-looking statements. Kinaxis assumes no obligation to update or revise any forward-looking statements, future-oriented financial information or financial outlook whether as a result of new information, future events or otherwise, except as expressly required by law..
SOURCE: Kinaxis Inc.
Kinaxis Inc.
Condensed Consolidated Interim Statements of Financial Position
(Expressed in thousands of USD)
December 31, December 31,
2025 2024
------------------------------------------ -------------- ----------------
Assets
Current assets:
Cash and cash equivalents $ 149,614 $ 172,192
Short-term investments 175,095 126,307
Trade and other receivables 165,781 156,394
Prepaid expenses 15,743 18,244
------------------------------------------ --------- ---------
506,233 473,137
Non-current assets:
Unbilled receivables 1,596 1,448
Other receivables 1,047 867
Prepaid expenses 1,558 2,072
Deferred tax assets 18,225 11,016
Contract acquisition costs 37,038 32,005
Property and equipment 28,526 32,486
Right-of-use assets 43,090 46,705
Intangible assets 10,804 12,865
Goodwill 76,597 72,735
------------------------------------------ --------- ---------
218,481 212,199
$ 724,714 $ 685,336
------------------------------------------ --------- ---------
Liabilities and Shareholders' Equity
Current liabilities:
Trade payables and accrued
liabilities $ 90,040 $ 94,913
Deferred revenue 161,060 140,008
Lease obligations 5,938 5,587
------------------------------------------ --------- ---------
257,038 240,508
Non-current liabilities:
Lease obligations 42,065 43,348
Deferred tax liabilities 4,042 5,969
------------------------------------------ --------- ---------
46,107 49,317
Shareholders' equity:
Share capital 363,246 329,312
Contributed surplus -- 12,078
Accumulated other comprehensive loss (223) (3,847)
Retained earnings 58,546 57,968
------------------------------------------ --------- ---------
421,569 395,511
$ 724,714 $ 685,336
------------------------------------------ --------- ---------
Kinaxis Inc.
Condensed Consolidated Interim Statements of Comprehensive Income
(Expressed in thousands of USD, except share and per share data)
Three months ended December
31, Year ended December 31,
2025 2024 2025 2024
--------------------- --------------- ------------ ----------- --------------
Revenue $ 144,235 $ 123,935 $ 548,030 $ 483,111
Cost of revenue 49,976 48,833 193,752 188,528
Gross profit 94,259 75,102 354,278 294,583
Operating expenses:
Selling and
marketing 28,216 25,624 115,083 100,531
Research and
development 25,648 21,310 94,041 87,653
General and
administrative 16,607 31,172 65,672 93,661
--------------------- ---------- ---------- ---------- ----------
70,471 78,106 274,796 281,845
23,788 (3,004) 79,482 12,738
Other income:
Foreign
exchange gain 356 927 2,561 682
Net finance and
other income 2,686 2,829 10,843 11,732
--------------------- ---------- ---------- ---------- ----------
3,042 3,756 13,404 12,414
Profit before income
taxes 26,830 752 92,886 25,152
Income tax expense 7,329 17,068 22,187 25,096
Profit (loss) 19,501 (16,316) 70,699 56
Other comprehensive
income (loss):
Items that are or may
be reclassified
subsequently to
profit
Foreign
currency
translation
differences -
foreign
operations (1,226) (4,660) 2,285 (3,563)
Change in
valuation of
cash flow
hedges 479 (1,389) 1,339 (1,644)
--------------------- ---------- ---------- ---------- ----------
(747) (6,049) 3,624 (5,207)
Total comprehensive
income (loss) $ 18,754 $ (22,365) $ 74,323 $ (5,151)
--------------------- ---------- ---------- ---------- ----------
Basic earnings (loss)
per share $ 0.70 $ (0.58) $ 2.51 $ --
Weighted average
number of basic
Common Shares 28,019,320 28,132,782 28,153,453 28,243,305
Diluted earnings
(loss) per share $ 0.68 $ (0.58) $ 2.45 $ --
Weighted average
number of diluted
Common Shares 28,586,942 28,132,782 28,845,750 28,939,759
--------------------- ---------- ---------- ---------- ----------
Kinaxis Inc.
Condensed Consolidated Interim Statements of Changes in Shareholders' Equity
(Expressed in thousands of USD)
Accumulated other comprehensive income
(loss)
---------------------------------------
Currency
Share Contributed Cash flow translation Retained Total
capital surplus hedges adjustments Total earnings equity
-------------- --------- ------------- ------------ --------------- -------- --------- -----------
Balance,
December 31,
2023 $307,327 $ 44,339 $ 441 $ 919 $ 1,360 $101,802 $454,828
Profit -- -- -- -- -- 56 56
Other
comprehensive
loss -- -- (1,644) (3,563) (5,207) -- (5,207)
-------------- ------- -------- ------ ------- ------ ------- -------
Total
comprehensive
income
(loss) -- -- (1,644) (3,563) (5,207) 56 (5,151)
Share options
exercised 28,065 (6,512) -- -- -- -- 21,553
Restricted
share units
vested 14,992 (14,992) -- -- -- -- --
Deferred share
units vested 1,396 (1,396) -- -- -- -- --
Performance
share units
vested 5,533 (5,533) -- -- -- -- --
Share-based
payments -- 40,723 -- -- -- -- 40,723
Shares
repurchased (9,837) (44,551) -- -- -- (43,890) (98,278)
Obligations
related to
share
repurchases (18,164) -- -- -- -- -- (18,164)
-------------- ------- -------- ------ --- ------- ------ ------- -------
Total
shareholder
transactions 21,985 (32,261) -- -- -- (43,890) (54,166)
Balance,
December 31,
2024 $329,312 $ 12,078 $(1,203) $ (2,644) $(3,847) $ 57,968 $395,511
Profit -- -- -- -- -- 70,699 70,699
Other
comprehensive
income -- -- 1,339 2,285 3,624 -- 3,624
-------------- ------- -------- ------ --- ------- ------ ------- -------
Total
comprehensive
income -- -- 1,339 2,285 3,624 70,699 74,323
Share options
exercised 26,742 (6,390) -- -- -- -- 20,352
Restricted
share units
vested 24,937 (24,937) -- -- -- -- --
Deferred share
units vested 810 (810) -- -- -- -- --
Performance
share units
vested 3,553 (3,553) -- -- -- -- --
Share-based
payments -- 40,380 -- -- -- -- 40,380
Shares
repurchased (10,141) (16,768) -- -- -- (70,121) (97,030)
Change in
obligation
for share
repurchases (11,967) -- -- -- -- -- (11,967)
-------------- ------- -------- ------ --- ------- ------ ------- -------
Total
shareholder
transactions 33,934 (12,078) -- -- -- (70,121) (48,265)
Balance,
December 31,
2025 $363,246 $ -- $ 136 $ (359) $ (223) $ 58,546 $421,569
-------------- ------- -------- ------ --- ------- ------ ------- -------
Kinaxis Inc.
Condensed Consolidated Interim Statements of Cash Flows
(Expressed in thousands of USD)
Three months ended
December 31, Year ended December 31,
2025 2024 2025 2024
---------------------- ------------- ---------- ---------- ------------
Cash flows from
operating activities
Profit (loss) $ 19,501 $ (16,316) $ 70,699 $ 56
Items not
affecting cash:
Depreciation
of property
and
equipment
and
right-of-use
assets 3,732 4,726 16,502 19,614
Amortization
of
intangible
assets 854 1,320 3,345 5,314
Impairment
loss on
intangible
assets -- 4,521 -- 4,521
Share-based
payments 9,263 10,228 39,015 39,581
Net finance
income (2,748) (2,757) (10,817) (11,508)
Income tax
expense 7,329 17,068 22,187 25,096
Investment
tax credits
recoverable -- 11,271 -- 8,362
Change in
operating assets
and liabilities (5,922) (8,814) 3,478 900
Interest received 3,651 3,750 13,257 14,137
Interest paid (554) (437) (2,004) (1,714)
Income taxes paid (5,164) (443) (37,862) (5,146)
---------------------- -------- -------- -------- --------
29,942 24,117 117,800 99,213
Cash flows from (used
in) investing
activities
Purchase of
property and
equipment (674) (2,268) (5,689) (4,515)
Purchase of
short-term
investments (164,608) (103,316) (619,089) (342,076)
Redemption of
short-term
investments 196,936 87,855 569,684 332,972
---------------------- -------- -------- -------- --------
31,654 (17,729) (55,094) (13,619)
Cash flows used in
financing activities
Payment of lease
obligations (1,471) (1,603) (5,838) (6,963)
Repurchase of
shares (36,008) (19,996) (97,030) (98,278)
Proceeds from
exercise of
stock options 742 7,969 20,352 21,553
---------------------- -------- -------- -------- --------
(36,737) (13,630) (82,516) (83,688)
Increase (decrease) in
cash and cash
equivalents 24,859 (7,242) (19,810) 1,906
Cash and cash
equivalents,
beginning of year 126,476 183,228 172,192 174,844
Effects of exchange
rates on cash and
cash equivalents (1,721) (3,794) (2,768) (4,558)
---------------------- -------- -------- -------- --------
Cash and cash
equivalents, end of
year $ 149,614 $ 172,192 $ 149,614 $ 172,192
---------------------- -------- -------- -------- --------
View source version on businesswire.com: https://www.businesswire.com/news/home/20260304540878/en/
CONTACT: Investor Relations
Rick Wadsworth | Kinaxis
rwadsworth@kinaxis.com
613-907-7613
Media Relations
Vanessa Cohen | Kinaxis
vcohen@kinaxis.com
647-822-8540
(END) Dow Jones Newswires
March 04, 2026 17:01 ET (22:01 GMT)